Postexposure prophylaxis with nirmatrelvir-ritonavir does not cut COVID-19 infection
by Elana GotkinePostexposure prophylaxis with nirmatrelvir-ritonavir for five or 10 days does not reduce the risk for symptomatic severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection
Updated on: July 31,2024
0
Postexposure prophylaxis with nirmatrelvir-ritonavir does not cut COVID-19 infection
by Elana GotkinePostexposure prophylaxis with nirmatrelvir-ritonavir for five or 10 days does not reduce the risk for symptomatic severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection
Updated on:July 31,2024
0